Applications of GnRH analogues in infertility treatment

Česká verzia

Authors: I. Crha ; R. Hudeček; M. Huser
Authors place of work: Gynekologicko-porodnická klinika, LF MU a FN Brno
Published in the journal: Prakt Gyn 2011; 15(3-4): 152-156
Category: Review Article

Summary

Objective to provide the most up to date overview of gonadotropin-releasing hormone (GnRH) analogues application in human infertility treatment. Papers extracted from the Cochrane Library of Reviews and Protocols, Database of Abstracts of Reviews of Effects (DARE), MEDLINEplus and the treatment guidelines used in our Assisted Reproduction Centre were analysedGnRH analogues are used in the treatment of endometriosis, uterine fibromyomas, in ovarian stimulation protocols and for fertility protection during gonadotoxic treatment. GnRH analogues represent a very effective way of treatment of fertility disorders.

Key words:
GnRH analogues – triptorelin – infertility – endometriosis – uterine fibroids

Zdroje

1. Ascheim S, Zondek B. Hypophysenvorderlappenhormone und ovarialhormon im Harn von Schwangeren. Kim Wochenschr 1927; 6: 1322.

2. Schally AV. Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis. Peptides 1999; 20(10): 1247–1262.

3. Conn PM, Crowley WF Jr. Gonadotropin-releasing hormone and its analogs. Annu Rev Med 1994; 45: 391–405.

4. Leyendecker G, Wildt L, Hansmann M. Pregnacies following chronic intermittent (pulsatile) administration of Gn-RH by means of a portable pump (“Zyklomat”) – a new approach to the treatment of infertility in hypothalamic amenorrhoea. J Clin Endocrinol Metab 1980; 51(5): 1214–1216.

5. Porter RN, Smith W, Craft IL et al. Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet 1984; 2(8414): 1284–1285.

6. Smitz J, Devroey P, Camus M et al. The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT. Hum Reprod 1988; 3(5): 585–590.

7. Huser M, Crha I, Ventruba P et al. Prevention of ovarian function damage by a GnRH analogues during chemotherapy in Hodgkin lymphoma patients. Hum Reprod 2008; 23(4): 863–868.

8. Stanger JD, Yovich JL. Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol 1985; 92(4): 385–393.

9. Albuquerque LE, Saconato H, Maciel MC. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles. Cochrane Database Syst Rev 2005; 1: CD002808.

10. Tarlatzis BC, Kolibianakis EM. GnRH agonists vs antagonists. Best Pract Res Clin Obstet Gynaecol 2007; 21(1): 57–65.

11. Al-Inany H, Aboulghar M. GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod 2002; 17(4): 874–885.

12. Crha I, Juránková E. Poruchy plodnosti podmíněné endometriózou. Gynekol Prax 2006; 4: 203–208.

13. Bokor A, Kyama CM, Vercruysse L et al. Density of small diameter sensory nerve fibres in endometrium: a semi-invasive diagnostic test for minimal to mild endometriosis. Hum Reprod 2009; 24(12): 3025–3032.

14. Bulun SE, Zeitoun KM, Takayama K et al. Molecular basis for treating endometriosis with aromatase inhibitors. Hum Reprod Update 2000; 6(5): 413–418.

15. Kennedy S, Berqqvist A, Chapron C et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 2005; 20(10): 2698–2704.

16. Hughes E, Fedorkow D, Collins J et al. Ovulation suppression for endometriosis. Cochrane Database Syst Rev 2003; 3: CD000155.

17. Mára M, Holub Z et al. Děložní myomy – moderní diagnosti a léčba. Praha: Grada 2009.

18. Krajčovičová R, Hudeček R. Vliv děložní myomatózy na reprodukční funkce. Prakt Gyn 2010; 14(4): 154–163.

19. Huser M, Crha I, Hudecek R et al. Ovarian tissue cryopreservation - new opportunity to preserve fertility in female cancer patients. Eur J Gynaecol Oncol 2007; 28(4): 249–256.